Conferences &
Events

Upcoming conferences and events

May 19 – 20, 2022

Convening the world’s leading clinicians, industry executives, investors, patient advocates, payers, policy experts, and researchers, the 16th Annual Personalized Medicine Conference will facilitate a cross-sector exchange of perspectives on the scientific, business, and policy issues influencing the status and outlook for personalized medicine in the wake of a devastating pandemic that has upended the health care landscape.

Speaker: Catherine Sanders, PhD

Topic(s): COVID-19 and the Next Steps for Medicine: A Panel Discussion About Personalized Medicine in the Post-Pandemic Era (May 19th @ 10:15 am ET)

Molecular diagnostics, more sophisticated approaches to analyzing health care data, and molecularly guided treatments for non-oncologic indications are expanding the frontiers of personalized medicine outside of oncology. But progress remains uneven across disease states. During this panel discussion, leaders in the field will join us to explore the opportunities and challenges for personalized medicine in multiple disease states.

June 3-7, 2022

ASCO offers presentations on the latest research in cancer care. This year’s program will feature sessions complementing the meeting’s theme: Advancing Equitable Cancer Care Through Innovation.

June 13-16, 2022

Speaker: Sharon Benzeno, PhD

Topic(s): Defining Correlates of Protection for COVID-19: The Technology is Here, The Time is Now (June 14th, 1:45-2:45pm PT)

Despite mounting evidence that we need to look at the entire immune response, many academics, government researchers and vaccine makers are failing to include T-cell metrics in their studies. As a result, key questions remain unanswered: How long do vaccines last? Does everyone need a booster?

June 21-24, 2022

The FOCIS Annual Meeting brings together researchers and clinicians in translational immunology to share knowledge across traditional disease borders and identify commonalities between treatments and therapies that are life-changing for those affected with immune-mediated diseases.

Speaker: Harlan Robins, PhD

June 21-22, 2022

LSX aims to provide the world’s most influential and powerful global platform that will nurture and develop cross-industry partnerships, connect innovation to capital and forge and deepen relationships that will underpin the success of the global life science and healthcare industries.

Speaker: Sharon Benzeno, PhD

Topic: ‘Commercializing in the US’ table, June 22nd, 12:10 pm. ‘Company Panel: When and why to build clinical and commercial support,’ June 22nd, 9.45am

June 28-30, 2022

PMWC gathers recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors and showcases the latest practical content that helps close the knowledge gap among different sectors.

Speaker: Sharon Benzeno, PhD

Topic: Cell-based Therapy Challenges (Panel)

Previous conferences and events

April 20-21, 2022

Life Science Innovation Northwest is the Pacific Northwest’s largest annual life science conference bringing together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community for a two-day event to discuss and feature some of the most compelling technology breakthroughs of our time.

Speaker: Harlan Robins, PhD; Mark Adams, PhD

Topic(s): Next Frontier for Cell Therapies and Autoimmune Disorders (April 21st, 1:10 pm – 2:00 pm PT), Diagnostics (April 20th, 10:00 am – 12:00 pm PT)

April 18-21, 2022

The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain.

Speaker(s): Sharon Benzeno, PhD; Patrick Raber, PhD

Topic(s): Immune Profiling: Lessons learned from the coronavirus pandemic to help inform future vaccine development (April 20th, 09:10); T-cell Immune Response: Exploring emerging themes in vaccine development and COVID-19 variants (April 20th, 3:40)

  • What have we learnt from monitoring the immune responses to SARS-CoV-2 vaccines in different populations?
  • How can this help inform future vaccine development?
  • Why did the majority of mRNA vaccines work so well? What research has been done to understand the efficacy of these vaccines?

April 8-13, 2022

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

Speaker: Patrick Raber, PhD

Topic(s): Adaptive Symposium: Advancing cancer and immunotherapy research with immunosequencing

Mar 16-18, 2022

IO360˚ convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.

Speaker: Sharon Benzeno PhD

Topic(s): Antigen-specific TCR discovery at scale to inform immune-based therapies (Thursday, March 17 4:45pm ET); Assessing the Opportunities for IO 2.0 (Thursday, March 17, 12:05PM ET)

Jan 10th, 2022 @ 1:30pm (EST)

Speaker: CEO and Co-founder Chad Robins

Dec 11-14, 2021

The premier event in malignant and non-malignant hematology. Join us at the Georgia World Congress Center in Atlanta, Georgia – or virtually – from December 11-14, 2021, to discover the newest advances in hematology. 

Nov 30-Dec 1, 2021

The World Vaccine & Immunotherapy Congress is part of an award-winning series of conferences and exhibitions that are continuously growing becoming the largest and most established vaccine meetings of its kind across the globe.

Speaker(s): Sharon Benzeno PhD; Lance Baldo MD

Topic(s): TCRs from discovery to therapeutics  (Sharon Benzeno, Nov 30: 3:10 pm)

Nov 10-Nov 14, 2021

The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. 

Nov 10, 2021 @ 8:00am (PST)

In this webcast, Dr. Thomas Snyder and Dr. Jabran Zahid will discuss how immunosequencing and identification of public T-cell receptor responses can be used to characterize HLA type and make connections of HLA to disease biology, immune response, and immune-driven therapies.

Speaker(s): Thomas Snyder PhD; Jabran Zahid PhD (Microsoft Research)

Topic(s): Using immunosequencing to characterize HLA and its role in disease

July 20-21, 2021

Two day virtual event bringing together those currently working hard to ease the globe out of the COVID-19 pandemic, and to prevent it from happening again.

Speaker: Harlan Robins, PhD; Lance Baldo, MD

Topic(s): Keynote Panel – COVID-19: Where are we now, and what needs to happen next?; Using machine learning to develop clinical tests for infectious diseases

June 14-18, 2021

Precision Medicine in the Era of a Pandemic Recovery

Speaker(s): Julie Rubinstein; Lance Baldo, MD; Sharon Benzeno, PhD; Harlan Robins, PhD

Topic(s): SARS-CoV-2 Vaccines: Updates on Recent Developments and RWD/RWE Results, Novel Technologies to Advance Cell Therapies for Cancer, Using Immune Response Information to Develop Therapeutics in New Disease Areas

May 13th, 2021 @ 12pm (ET)

This briefing will be hosted by Adaptive Biotechnologies and the Personalized Medicine Coalition in cooperation with Rep. Tom Emmer (R-MN), Rep. Eric Swalwell (D-CA), Sen. Tim Scott (R-SC), and Sen. Kyrsten Sinema (D-AZ).

Cynthia Bens of the Personalized Medicine Coalition will moderate a discussion with leading experts.

Speaker: Lance Baldo, MD

Topic(s): Understanding the Immune Response to COVID-19

May 12th, 2021

This three-day conference will convene experts in immuno-oncology to discuss the latest research in the field. Topics under consideration will include how insights from the immune response to infection can inform our understanding of cancer immunotherapy, the COVID-19/Immuno-oncology interface, advances in multiple myeloma, cytokines, novel checkpoints and more.

Speaker: Harlan Robins, PhD

Topic: Cell therapy in solid tumors: Freedom of the open road

STAT May 11th, 2021

Biology and technology are converging to change medicine. Join us for the 2021 STAT Health Tech Summit, which will bring you inside this transformation, with probing interviews, lively panels, and exciting demos.

Speaker: Mark Adams, PhD

May 5th, 2021

Since 1989, Cancer Progress is the only oncology conference that facilitates discussions of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives over three days of provocative, informative panel discussions.

Speaker: Sharon Benzeno, PhD

Topic: Cell therapy in solid tumors: Freedom of the open road

WVC May 4th-6th, 2021

The World Vaccine Congress is the largest, most established meeting dedicated to vaccines. From basic research to commercial manufacture, this one meeting covers the whole vaccine value chain where science, government and manufacturers all come together to create groundbreaking progress.

Speaker(s): Sharon Benzeno, PhD; Harlan Robins, PhD

Topic(s): Can Adjuvants and Immune Profiling Improve Our Immune Response to Current COVID Vaccines?, T-Cell Immune Response: Exploring Emerging Themes in Vaccine Development and COVID-19 Variants

February 11th, 2021 @ 9AM (PST)

Meet the managers for our Laboratory Operations group: Stephanie Skelton, and Michael Dauer. They will be presenting information about their respective groups, the work we are doing at Adaptive, and what types of roles they are hiring for. Stick around after their presentation to speak with a member from our Talent Acquisition team.

PMWC January 25-27, 2021 @ 9:30AM (PST)

21st Century Precision Medicine in the Age of COVID-19

Speaker: Dr. Lance Baldo, Chief Medical Officer

Topic: Deciphering The COVID-19 Immune Response

January 11th, 2021 @ 1:30pm (PST) / 4:30pm
(EST)

Speaker: CEO and Co-founder Chad Robins

ASH December 5th-8th
The premier event in malignant and non-malignant hematology
ASH December 5th-8th
The premier event in malignant and non-malignant hematology